Dr. David Y. Lin, DO

Dr. Lin practices at David Lin's Medical Clinic in Rosemead, California.

Dr. Lin's NPI, 1679635353, was assigned on December 15, 2006. Dr. Lin graduated from Heritage College of Osteopathic Medicine in 1994. Dr. Lin holds California license 20A6729.

Dr. Lin's primary practice is David Lin's Medical Clinic, at 3925 N Rosemead Blvd Ste 101, Rosemead, CA 91770-1933. The practice phone is (626) 625-5543.

Dr. Lin's primary practice is David Lin's Medical Clinic in Rosemead, California. Dr. Lin is also affiliated with USC Arcadia Hospital. Dmand AI also links Dr. Lin to 5 more hospitals, 5 home health agencies and 5 skilled nursing facilities, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 17 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lin is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lin is licensed in California.

Dmand AI lists acid reflux, acute respiratory failure, acute skin infection, anemia, aneurysm, anxiety, aortic atherosclerois and arthritis among the conditions Dr. Lin treats.

CMS data shows 13,069 Medicare services from Dr. Lin across 18 procedure codes in 2024, for 847 Medicare patients. Medicare paid $875,194 for them.

CMS counts 847 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 83% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 72, with 54% women.

In 2024, Dr. Lin wrote 38,401 Medicare Part D claims for 1,044 patients. 85% of them were for generic drugs. CMS names the drug for 37,530 of them, across 314 drugs with 11 or more claims each, at $3,682,181 in total drug cost. In 2023, CMS named 35,143 claims across 294 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lin for performance year 2024, reported individually. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Lin, published from 2012 to 2025. Dr. Lin's most frequent co-author is Yuan Yuan, MD, PhD.

CMS Open Payments shows 1,218 general payments to Dr. Lin from 64 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amarin Pharma Inc. paid the most, $6,279.

Dmand AI lists 1 award for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from Heritage College of Osteopathic Medicine in 1994.

Dr. Lin is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.